Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 39.3B | 35.1B | 30.0B | 26.0B |
| Cost of revenue | 10.6B | 8.9B | 7.5B | 5.6B |
| Gross profit | 28.7B | 26.2B | 22.6B | 20.4B |
| Operating expense | ||||
| Research & development | 3.7B | 3.4B | 3.1B | 2.7B |
| Selling general and admin | 975M | 897M | 842M | 777M |
| Other operating expenses | — | — | — | — |
| Operating income | 24.0B | 21.9B | 18.6B | 16.9B |
| Non operating interest income | ||||
| Income | 511M | 472M | 444M | 359M |
| Expense | 61M | 61M | 61M | 64M |
| Other income expense | 733M | 36M | 189M | 75M |
| Pretax income | 25.2B | 22.3B | 19.2B | 17.3B |
| Tax provision | 3.1B | 3.0B | 2.6B | 2.4B |
| Net income | 22.1B | 19.3B | 16.6B | 14.9B |
| Basic EPS | — | 0.8 | 0.7 | 0.6 |
| Diluted EPS | — | 0.8 | 0.7 | 0.6 |
| Basic average shares | — | 6.5B | 6.5B | 6.5B |
| Diluted average shares | — | 6.6B | 6.6B | 6.6B |
| EBITDA | 25.8B | 22.9B | 19.7B | 17.8B |
| Net income from continuing op. | 22.1B | 19.3B | 16.6B | 14.9B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |